Extracorporeal Shockwave Therapy & Neural Mobilization for Carpal Tunnel Syndrome
Extracorporeal Shockwave Therapy & Neural Mobilization for Carpal Tunnel Syndrome
Study on the effect, safety, prognosis quality and application value of extracorporeal shock wave based neural activity in carpal tunnel syndrome patients.
BMC Musculoskelet Disord. 2023 Mar 13;24(1): 186.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
92 patients with mild-moderate carpal tunnel syndrome were randomized to receive neural mobilization plus 4 weeks of extracorporeal shockwave therapy (n=47) or neural mobilization alone (n=45). Outcomes of interest included clinical efficacy, symptom improvement, and pain scores, median nerve electrophysiological examination, upper limb function, and symptom scores as measured by the Boston Carpal...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.